A Retrospective Case-Control Study of the Relationship between the Gut Microbiota, Enteropathy, and Child Growth

Area of Science:

• Microbiome research
• Pediatric growth studies
• Environmental enteropathy

Background:

• Child gut microbial communities are crucial for growth, but the exact relationship remains unclear.
• Environmental enteropathy (EE) is a subclinical intestinal condition affecting children in low-resource settings.
• Understanding the gut microbiome's role in child growth and EE is vital for public health.

Purpose of the Study:

• To investigate the association between gut microbial composition and child growth in a Bangladeshi cohort.
• To explore the relationship between environmental enteropathy markers and gut microbiota changes.
• To identify specific bacterial taxa linked to poor linear growth in young children.

Main Methods:

• Prospective study of 68 children over 18 months in Mirzapur, Bangladesh.
• Fecal samples analyzed for environmental enteropathy markers (alpha-1-antitrypsin, calprotectin, myeloperoxidase, neopterin).
• 16S rRNA gene sequencing to characterize gut microbial communities (ASVs) and age-matched growth comparisons.

Main Results:

• Elevated EE markers correlated with poor linear growth in children.
• Children with poor growth exhibited distinct gut microbial profiles.
• Increased abundance of Escherichia/Shigella and Proteobacteria, and decreased Prevotella were observed in poorly growing children.

Conclusions:

• Gut microbial dysbiosis and intestinal inflammation are associated with impaired child growth.
• Findings highlight the interplay between gut microbiota, EE, and child development.
• Further research is warranted in low- and middle-income countries to confirm these associations.